Joan Cox Gill

Children's Hospital of Wisconsin — United States

Medicine · Health Sciences

45h-index5.8kcitations172works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Platelet Disorders and Treatments(112), Hemophilia Treatment and Research(61), Blood groups and transfusion(49), Heparin-Induced Thrombocytopenia and Thrombosis(32), Blood Coagulation and Thrombosis Mechanisms(27)

Publications172 total

Rituximab for treatment of inhibitors in haemophilia A: A Phase II Study
UNC Libraries·2020· 4 citedOpen Access
Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy
Blood Advances·2020· 31 citedOpen Access
Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease
American Journal of Hematology·2019· 17 citedOpen Access
Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia
Haemophilia·2019· 11 citedOpen Access
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
Research and Practice in Thrombosis and Haemostasis·2019· 20 citedOpen Access
Sustained high trough factor IX activity levels with continued use of rIX‐FP in adult and paediatric patients with haemophilia B
Haemophilia·2019· 17 citedOpen Access
Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program
Blood·2018· 1 cited
Variability in Bleeding Phenotype in Type 3 VWD Families
Blood·2018
Risk factors associated with invasive orthopaedic interventions in males with haemophilia enrolled in the Universal Data Collection program from 2000 to 2010
Haemophilia·2018· 7 citedOpen Access
A cross-sectional analysis of cardiovascular disease in the hemophilia population
Blood Advances·2018· 66 citedOpen Access
Von Willebrand disease in the United States: perspective from the Zimmerman program
Annals of Blood·2018· 21 citedOpen Access
Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD
Blood·2017· 2 cited
Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD
Blood·2017· 2 cited
Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program
Blood·2017· 4 cited
Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors
Journal of Thrombosis and Haemostasis·2017· 16 citedOpen Access
Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project
Blood·2017· 161 citedOpen Access
Identification of Copy Number Variants in Type 1 and Type 3 VWD by aCGH in the Zimmerman Program
Blood·2016· 1 cited
Von Willebrand Factor (VWF) Propeptide and Factor VIII (FVIII) Levels Identify the Contribution of Decreased Synthesis and/or Increased Clearance Mechanisms in the Pathogenesis of Type 1 Von Willebrand Disease (VWD) in the Zimmerman Program
Blood·2016
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System
Haemophilia·2016· 80 citedOpen Access
Survey of the anti–factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence‐based immunoassay
Journal of Thrombosis and Haemostasis·2016· 14 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Robert R. Montgomery(15), Amy D. Shapiro(9), Sandra L. Haberichter(8), Pamela A. Christopherson(8), Veronica H. Flood(8), Kenneth D. Friedman(8), Thomas C. Abshire(8), Cindy Leissinger(7), Margaret V. Ragni(7), Patricia A. Morateck(6), Marilyn J. Manco‐Johnson(6), Jeanne M. Lusher(6), Raymond G. Hoffmann(5), W. Keith Hoots(5), Peter A. Kouides(5), Daniel B. Bellissimo(4), Craig M. Kessler(4), Bruce M. Ewenstein(4), Christine L. Kempton(4), Nigel S. Key(4)